Test Price
600 AED✅ Home Collection Available
Fever SARS-CoV-2 Panel in Dubai | 600 AED | DHA-Aligned Diagnostic Assessment
Executive Summary & Core Metrics
Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via multiplex RT-PCR, CLIA serology, and laser flow cytometry under ISO 15189 standards.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Post-Test Guidance: Complimentary telephonic clinical interpretation provided by a DHA-licensed general practitioner.
- Insurance Verification: Direct billing confirmation available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Fever SARS-CoV-2 Panel is a comprehensive DHA-aligned diagnostic assessment that integrates multiplex real-time RT-PCR for respiratory pathogens, high-sensitivity chemiluminescent immunoassay (CLIA) serology, and complete blood count analysis via laser flow cytometry. This multi-parametric approach enables rapid differentiation of COVID-19 from other febrile illnesses, supporting precise clinical decision-making.
| Feature | Fever SARS-CoV-2 Panel | Standalone Rapid Antigen Test |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity (PCR + serology + CBC) | 60–85% sensitivity (antigen only) |
| Method | Multiplex Real-Time RT-PCR, CLIA serology, Laser Flow Cytometry | Lateral Flow Immunochromatography |
| Turnaround | 2 days | 15 minutes |
| Scope | Viral RNA, antibody response, hematological markers | Single antigen target only |
Physician Insight & Safety Protocols
“In my clinical practice, evaluating a febrile patient requires more than a single target test. This panel's integrated design—combining molecular, serological, and hematological data—equips us to confirm or exclude SARS-CoV-2 while concurrently ruling out common co-infections. Such comprehensive profiling shortens diagnostic uncertainty and supports targeted therapy. Always interpret laboratory findings alongside the patient’s full clinical presentation.”
– Dr. Ajay Singh, General Practitioner, DHA License 36234132
Important Advisory
Exclusion Criteria & Emergency Red Flags
- Home Collection Restriction: Patients experiencing severe dyspnea requiring supplemental oxygen, unstable vital signs, or children under 2 years of age must be directed to an emergency department or hospital-based collection centre.
- Anticoagulant Use: Inform the phlebotomist if you are taking blood thinners such as warfarin to ensure appropriate post-collection care.
- Emergency Warning Signs: Seek immediate emergency care if you develop severe shortness of breath, persistent chest pain, confusion, cyanosis of lips or face, or high fever unresponsive to antipyretics.
Patient FAQ & Clinical Guidance
1. What conditions does the Fever SARS-CoV-2 Panel evaluate?
This panel simultaneously detects SARS-CoV-2 viral RNA via RT-PCR, measures specific antibodies through CLIA serology, and assesses haematological parameters to differentiate COVID-19 from other febrile syndromes such as influenza, bacterial pneumonia, or viral upper respiratory tract infections.
2. How should I prepare for sample collection?
Overnight fasting is recommended for the blood draw component. A combined nasopharyngeal and oropharyngeal swab will be collected alongside two blood samples (serum and whole blood). Follow all instructions provided by the mobile phlebotomy team to ensure specimen integrity.
3. When will my results be available and how are they communicated?
Results are typically reported within 2 days of sample receipt. A DHA-licensed physician will contact you via telephone to explain all findings in clinical context and answer any questions you may have regarding next steps.
4. Can this panel replace a doctor’s consultation?
No. This test provides diagnostic data that must be interpreted by a qualified healthcare professional in the context of your full medical history and physical examination. Always follow the clinical guidance provided by your treating physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and strictly complies with all applicable UAE federal regulations governing health data and laboratory practice. Patient information and test results are processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 15189 accredited, ensuring the highest standards of quality and confidentiality.
Clinical & Logistical Metadata
| Test Name | Fever SARS-CoV-2 Panel |
| Price (AED) | 600 AED |
| Turnaround Time | 2 days |
| Sample Type / Matrix | Nasopharyngeal & Oropharyngeal Swab, Serum, Whole Blood |
| Methodology Used | Multiplex Real-Time RT-PCR, CLIA Serology, Laser Flow Cytometry |
| ICD-10-CM Code | R50.9, Z11.52 |
| LOINC Code | 94534-5 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians